China successfully completes the country#s first human implantation of a retrievable transcatheter aortic valve

Food and Healthcare Press Releases Wednesday November 29, 2017 08:54
HANGZHOU, China--29 Nov--PRNewswire/InfoQuest
  • The success of the procedure unleashes a new era for retrievable interventional cardiac valve technology in China
The first human implantation of the VenusA Plus retrievable valve system was completed successfully at the Second Affiliated Hospital of Zhejiang University School of Medicine (SAHZU) on November 23, 2017.
https://photos.prnasia.com/prnvar/20171124/2000223-1

Prof. Wang Jian'an, president of SAHZU, announced that China has completed its first successful human implantation of a retrievable transcatheter aortic valve. It marks another milestone for Venus Medtech, becoming China's first company capable of providing a retrievable interventional cardiac valve system.

The 76-year-old female patient who was operated on using the system had been diagnosed with severe aortic valve stenosis and defined as a high-risk surgical patient. The heart team discussed and defined the patient's anatomical features as a bicuspid aortic valve and asymmetric calcification, which raised the risk of dislocation during the valve implantation. They were of the opinion that the retrievable system would be the best fit for the patient.

The retrievable system allows the valve to withdraw and reposition after release, avoiding adverse events as a result of a poor implant position and mismatch of the implanted valve, including valve translocation, severe paravalvular leakage, a negative impact on the bicuspid aortic valve and high degree atrioventricular block caused by conduction bundle compression. The system also reduces the complexity of the procedure, which, in turn, helps to promote the adoption and application of TAVR technology.

"SAHZU's medical team has been closely working with Zhejiang Province's Cardiac Valve Research Institute and Venus Medtech's R&D team to study, develop and produce the heart valve products. The collaboration began with the VenusA-Valve and has led to the success for VenusA Plus," professor Wang added. "The product is a next-generation TAVR valve that delivers good performance in terms of release, retrievable stability, controllability and passing ability, thus offering great potential when it comes to clinical applications."

The successful human implantation of VenusA Plus took place just four months after the launch of China's first TAVR valve VenusA-Valve. "Venus Medtech has continuously achieved technological breakthroughs," explained Venus Medtech CEO Zi Zhenjun. "We plan to roll out more innovative products going forward, demonstrating the company's strong competence in innovation and its ongoing commitment to serving patients."

Photo - https://photos.prnasia.com/prnh/20171124/2000223-1

Latest Press Release

Global Survey and Documentary Film Expose Emotional Impact of Multiple Sclerosis

- Merck-sponsored survey developed in collaboration with IACO and Eurocarers reveals lifelong effects of caring for a loved one with MS - #MSInsideOut documentary film, executively produced by Shift.ms, provides artistic take on the experiences of those...

The Menarini Group Announces Commercial Agreement for Vabomere, Orbactiv and Minocin in 68 Countries

Expands on existing commercial and co-development agreement for delafloxacin Consolidates company's strategic focus on infectious diseasesThe Menarini Group, an Italian biopharmaceutical company present in 136 countries worldwide, and Melinta...

Samitivej warns more Thais at risk of food allergies Failure to get treatment can cause a life-threatening reaction

According to Samitivej Allergy Institute, the number of Thais at risk from food allergies has surged by 300-400 percent in recent years as a result of lifestyle changes. The risk factors come from good living and more awareness of cleanliness, which have...

Doctors Talk: Tips to Recover from Training and Competition Like a Pro Athlete By Dr. Korakod Panich (M.D.), Herbalife Nutrition Advisory Board (NAB) Member

Doctor's Talk: Tips to Recover from Training and Competition Like a Pro Athlete By Dr. Korakod Panich (M.D.), Herbalife Nutrition Advisory Board (NAB) Member Have you ever felt that you have been exercising forever without getting anywhere near your...

Exosystems to conduct trial run of new ICT rehabilitation solution in Vietnam

The healthcare robotics company Exosystems will soon be conducting a trial run of its ICT muscular rehabilitation solution "ExoRehab" at hospitals in Vietnam. Exosystems, a member company of the K-ICT Born2Global Centre, has signed a partnership...

Related Topics